Nanocarriers for tracking and treating diseases

Sean Marrache, Rakesh Kumar Pathak, Kasey L. Darley, Joshua H. Choi, Dhillon Zaver, Nagesh Kolishetti, Shanta Dhar

Research output: Contribution to journalReview article

26 Citations (Scopus)

Abstract

Site directed drug delivery with high efficacy is the biggest challenge in the area of current pharmaceuticals. Biodegradable polymer-based controlled release nanoparticle platforms could be beneficial for targeted delivery of therapeutics and contrast agents for a myriad of important human diseases. Biodegradable nanoparticles, which can be engineered to load multiple drugs with varied physicochemical properties, contrast agents, and cellular or intracellular component targeting moieties, have emerged as potential alternatives for tracking and treating human diseases. In this review, we will highlight the current advances in the design and execution of such platforms for their potential application in the diagnosis and treatment of variety of diseases ranging from cancer to Alzheimer's and we will provide a critical analysis of the associated challenges for their possible clinical translation.

Original languageEnglish (US)
Pages (from-to)3500-3514
Number of pages15
JournalCurrent Medicinal Chemistry
Volume20
Issue number28
DOIs
StatePublished - Sep 1 2013
Externally publishedYes

Fingerprint

Nanoparticles
Contrast Media
Pharmaceutical Preparations
Biodegradable polymers
Drug delivery
Polymers
Neoplasms
Therapeutics

Keywords

  • Active targeting
  • Biomaterials
  • Blood-brain barrier
  • Cancer
  • Cardiovascular diseases
  • Liposome
  • Nanomedicine
  • Nanotechnology
  • Neurodegenerative diseases
  • Passive targeting
  • Polymer

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology

Cite this

Marrache, S., Pathak, R. K., Darley, K. L., Choi, J. H., Zaver, D., Kolishetti, N., & Dhar, S. (2013). Nanocarriers for tracking and treating diseases. Current Medicinal Chemistry, 20(28), 3500-3514. https://doi.org/10.2174/0929867311320280007

Nanocarriers for tracking and treating diseases. / Marrache, Sean; Pathak, Rakesh Kumar; Darley, Kasey L.; Choi, Joshua H.; Zaver, Dhillon; Kolishetti, Nagesh; Dhar, Shanta.

In: Current Medicinal Chemistry, Vol. 20, No. 28, 01.09.2013, p. 3500-3514.

Research output: Contribution to journalReview article

Marrache, S, Pathak, RK, Darley, KL, Choi, JH, Zaver, D, Kolishetti, N & Dhar, S 2013, 'Nanocarriers for tracking and treating diseases', Current Medicinal Chemistry, vol. 20, no. 28, pp. 3500-3514. https://doi.org/10.2174/0929867311320280007
Marrache S, Pathak RK, Darley KL, Choi JH, Zaver D, Kolishetti N et al. Nanocarriers for tracking and treating diseases. Current Medicinal Chemistry. 2013 Sep 1;20(28):3500-3514. https://doi.org/10.2174/0929867311320280007
Marrache, Sean ; Pathak, Rakesh Kumar ; Darley, Kasey L. ; Choi, Joshua H. ; Zaver, Dhillon ; Kolishetti, Nagesh ; Dhar, Shanta. / Nanocarriers for tracking and treating diseases. In: Current Medicinal Chemistry. 2013 ; Vol. 20, No. 28. pp. 3500-3514.
@article{9bd5ebcb89d947cb86cac089fa4ebb9a,
title = "Nanocarriers for tracking and treating diseases",
abstract = "Site directed drug delivery with high efficacy is the biggest challenge in the area of current pharmaceuticals. Biodegradable polymer-based controlled release nanoparticle platforms could be beneficial for targeted delivery of therapeutics and contrast agents for a myriad of important human diseases. Biodegradable nanoparticles, which can be engineered to load multiple drugs with varied physicochemical properties, contrast agents, and cellular or intracellular component targeting moieties, have emerged as potential alternatives for tracking and treating human diseases. In this review, we will highlight the current advances in the design and execution of such platforms for their potential application in the diagnosis and treatment of variety of diseases ranging from cancer to Alzheimer's and we will provide a critical analysis of the associated challenges for their possible clinical translation.",
keywords = "Active targeting, Biomaterials, Blood-brain barrier, Cancer, Cardiovascular diseases, Liposome, Nanomedicine, Nanotechnology, Neurodegenerative diseases, Passive targeting, Polymer",
author = "Sean Marrache and Pathak, {Rakesh Kumar} and Darley, {Kasey L.} and Choi, {Joshua H.} and Dhillon Zaver and Nagesh Kolishetti and Shanta Dhar",
year = "2013",
month = "9",
day = "1",
doi = "10.2174/0929867311320280007",
language = "English (US)",
volume = "20",
pages = "3500--3514",
journal = "Current Medicinal Chemistry",
issn = "0929-8673",
publisher = "Bentham Science Publishers B.V.",
number = "28",

}

TY - JOUR

T1 - Nanocarriers for tracking and treating diseases

AU - Marrache, Sean

AU - Pathak, Rakesh Kumar

AU - Darley, Kasey L.

AU - Choi, Joshua H.

AU - Zaver, Dhillon

AU - Kolishetti, Nagesh

AU - Dhar, Shanta

PY - 2013/9/1

Y1 - 2013/9/1

N2 - Site directed drug delivery with high efficacy is the biggest challenge in the area of current pharmaceuticals. Biodegradable polymer-based controlled release nanoparticle platforms could be beneficial for targeted delivery of therapeutics and contrast agents for a myriad of important human diseases. Biodegradable nanoparticles, which can be engineered to load multiple drugs with varied physicochemical properties, contrast agents, and cellular or intracellular component targeting moieties, have emerged as potential alternatives for tracking and treating human diseases. In this review, we will highlight the current advances in the design and execution of such platforms for their potential application in the diagnosis and treatment of variety of diseases ranging from cancer to Alzheimer's and we will provide a critical analysis of the associated challenges for their possible clinical translation.

AB - Site directed drug delivery with high efficacy is the biggest challenge in the area of current pharmaceuticals. Biodegradable polymer-based controlled release nanoparticle platforms could be beneficial for targeted delivery of therapeutics and contrast agents for a myriad of important human diseases. Biodegradable nanoparticles, which can be engineered to load multiple drugs with varied physicochemical properties, contrast agents, and cellular or intracellular component targeting moieties, have emerged as potential alternatives for tracking and treating human diseases. In this review, we will highlight the current advances in the design and execution of such platforms for their potential application in the diagnosis and treatment of variety of diseases ranging from cancer to Alzheimer's and we will provide a critical analysis of the associated challenges for their possible clinical translation.

KW - Active targeting

KW - Biomaterials

KW - Blood-brain barrier

KW - Cancer

KW - Cardiovascular diseases

KW - Liposome

KW - Nanomedicine

KW - Nanotechnology

KW - Neurodegenerative diseases

KW - Passive targeting

KW - Polymer

UR - http://www.scopus.com/inward/record.url?scp=84883215550&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883215550&partnerID=8YFLogxK

U2 - 10.2174/0929867311320280007

DO - 10.2174/0929867311320280007

M3 - Review article

VL - 20

SP - 3500

EP - 3514

JO - Current Medicinal Chemistry

JF - Current Medicinal Chemistry

SN - 0929-8673

IS - 28

ER -